Literature DB >> 20554030

CXCL12 alone is insufficient for gliomagenesis in Nf1 mutant mice.

Tao Sun1, Scott M Gianino, Erin Jackson, David Piwnica-Worms, David H Gutmann, Joshua B Rubin.   

Abstract

Tumorigenesis requires interactions between tumor progenitors and their microenvironment. We found that low cAMP levels were sufficient for tumorigenesis in a mouse model of Neurofibromatosis-1 (NF1)-associated optic pathway glioma (OPG). We hypothesized that the distinct pattern of glioma in NF1 reflected spatiotemporal differences in CXCL12 effects on cAMP levels. Thus, we sought to alter the pattern of gliomagenesis through manipulation of CXCL12-CXCR4 pathway activation in Nf1 OPG mice. Forced CXCL12 expression induced glioma at a low frequency. Further, treatment of Nf1 OPG mice with AMD3100, a CXCR4 antagonist, did not attenuate glioma growth. Thus, it appears, CXCL12 alone cannot promote gliomagenesis in NF1 mice. (c) 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20554030      PMCID: PMC2910179          DOI: 10.1016/j.jneuroim.2010.05.002

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  46 in total

1.  Loss of neurofibromatosis 1 (NF1) gene expression in NF1-associated pilocytic astrocytomas.

Authors:  D H Gutmann; J Donahoe; T Brown; C D James; A Perry
Journal:  Neuropathol Appl Neurobiol       Date:  2000-08       Impact factor: 8.090

2.  Targeted inhibition of cyclic AMP phosphodiesterase-4 promotes brain tumor regression.

Authors:  Patricia Goldhoff; Nicole M Warrington; David D Limbrick; Andrew Hope; B Mark Woerner; Erin Jackson; Arie Perry; David Piwnica-Worms; Joshua B Rubin
Journal:  Clin Cancer Res       Date:  2008-12-01       Impact factor: 12.531

3.  Cyclic AMP suppression is sufficient to induce gliomagenesis in a mouse model of neurofibromatosis-1.

Authors:  Nicole M Warrington; Scott M Gianino; Erin Jackson; Patricia Goldhoff; Joel R Garbow; David Piwnica-Worms; David H Gutmann; Joshua B Rubin
Journal:  Cancer Res       Date:  2010-06-15       Impact factor: 12.701

Review 4.  Dipeptidyl peptidase-IV enzymatic activity bearing molecules in human brain tumors--good or evil?

Authors:  Petr Busek; Jarmila Stremenova; Aleksi Sedo
Journal:  Front Biosci       Date:  2008-01-01

Review 5.  Chemokine signaling in cancer: one hump or two?

Authors:  Joshua B Rubin
Journal:  Semin Cancer Biol       Date:  2008-10-17       Impact factor: 15.707

Review 6.  Co-evolution of tumor cells and their microenvironment.

Authors:  Kornelia Polyak; Izhak Haviv; Ian G Campbell
Journal:  Trends Genet       Date:  2008-12-04       Impact factor: 11.639

7.  The oligodendroglial lineage marker OLIG2 is universally expressed in diffuse gliomas.

Authors:  Keith L Ligon; John A Alberta; Alvin T Kho; Jennifer Weiss; Mary R Kwaan; Catherine L Nutt; David N Louis; Charles D Stiles; David H Rowitch
Journal:  J Neuropathol Exp Neurol       Date:  2004-05       Impact factor: 3.685

8.  Synergy between CD26/DPP-IV inhibition and G-CSF improves cardiac function after acute myocardial infarction.

Authors:  Marc-Michael Zaruba; Hans Diogenes Theiss; Markus Vallaster; Ursula Mehl; Stefan Brunner; Robert David; Rebekka Fischer; Lisa Krieg; Eva Hirsch; Bruno Huber; Petra Nathan; Lars Israel; Axel Imhof; Nadja Herbach; Gerald Assmann; Ruediger Wanke; Josef Mueller-Hoecker; Gerhard Steinbeck; Wolfgang-Michael Franz
Journal:  Cell Stem Cell       Date:  2009-04-03       Impact factor: 24.633

9.  Neurofibromatosis-1 regulates neuronal and glial cell differentiation from neuroglial progenitors in vivo by both cAMP- and Ras-dependent mechanisms.

Authors:  Balazs Hegedus; Biplab Dasgupta; Jung Eun Shin; Ryan J Emnett; Elizabeth K Hart-Mahon; Lynda Elghazi; Ernesto Bernal-Mizrachi; David H Gutmann
Journal:  Cell Stem Cell       Date:  2007-10-11       Impact factor: 24.633

Review 10.  Neurofibromatosis type 1 revisited.

Authors:  Virginia C Williams; John Lucas; Michael A Babcock; David H Gutmann; Bruce Korf; Bernard L Maria
Journal:  Pediatrics       Date:  2009-01       Impact factor: 7.124

View more
  5 in total

1.  Radiation-induced Notch signaling in breast cancer stem cells.

Authors:  Chann Lagadec; Erina Vlashi; Yazeed Alhiyari; Tiffany M Phillips; Milana Bochkur Dratver; Frank Pajonk
Journal:  Int J Radiat Oncol Biol Phys       Date:  2013-08-27       Impact factor: 7.038

Review 2.  Neurofibromatosis type 1: modeling CNS dysfunction.

Authors:  David H Gutmann; Luis F Parada; Alcino J Silva; Nancy Ratner
Journal:  J Neurosci       Date:  2012-10-10       Impact factor: 6.167

Review 3.  Therapeutic advances for the tumors associated with neurofibromatosis type 1, type 2, and schwannomatosis.

Authors:  Jaishri O Blakeley; Scott R Plotkin
Journal:  Neuro Oncol       Date:  2016-02-06       Impact factor: 12.300

4.  Astrocyte TNFR2 is required for CXCL12-mediated regulation of oligodendrocyte progenitor proliferation and differentiation within the adult CNS.

Authors:  Jigisha R Patel; Jessica L Williams; Megan M Muccigrosso; Laindy Liu; Tao Sun; Joshua B Rubin; Robyn S Klein
Journal:  Acta Neuropathol       Date:  2012-08-30       Impact factor: 17.088

5.  CXCL12 mediates trophic interactions between endothelial and tumor cells in glioblastoma.

Authors:  Shyam Rao; Rajarshi Sengupta; Eun Joo Choe; B Mark Woerner; Erin Jackson; Tao Sun; Jeffrey Leonard; David Piwnica-Worms; Joshua B Rubin
Journal:  PLoS One       Date:  2012-03-12       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.